Asia Pacific High-Throughput Genomic Screening For Preventive Healthcare Market Size & Outlook
The high-throughput genomic screening for preventive healthcare market in Asia Pacific is expected to reach a projected revenue of US$ 412.2 million by 2033. A compound annual growth rate of 13.3% is expected of Asia Pacific high-throughput genomic screening for preventive healthcare market from 2026 to 2033.
- Clinical Diagnostics
- Genetic Testing
- High-Throughput Genomic Screening for Preventive Healthcare Market Outlook
- Genetic Testing
Revenue, 2025 (US$M)
$153.5
Estimate, 2026 (US$M)
$172.4
Forecast, 2033 (US$M)
$412.2
CAGR, 2026 - 2033
13.3%
Global Market
Related Markets
Ask Prism AI anything about the high-throughput genomic screening for preventive healthcare market
Get a cited answer from GVR research in seconds: segment shares, growth drivers, regulation and forecast assumptions.
Every answer starts with GVR research, and every figure is cited.Explore Prism AI
Asia Pacific high-throughput genomic screening for preventive healthcare market highlights
- The Asia Pacific high-throughput genomic screening for preventive healthcare market generated a revenue of USD 153.5 million in 2025.
- The market is expected to grow at a CAGR of 13.3% from 2026 to 2033.
- In terms of segment, non-invasive prenatal testing (nipt) was the largest revenue generating test type in 2025.
- Pharmacogenomic Testing is the most lucrative test type segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2026 to 2033.
Asia Pacific data book summary
| Market revenue in 2025 | USD 153.5 million |
| Market revenue in 2033 | USD 412.2 million |
| Growth rate | 13.3% (CAGR from 2026 to 2033) |
| Largest segment | Non-invasive prenatal testing (nipt) |
| Fastest growing segment | Pharmacogenomic Testing |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Carrier Screening, Predictive / Presymptomatic Testing, Non-Invasive Prenatal Testing (NIPT), Preimplantation Genetic Testing (PGT), Newborn Screening, Pharmacogenomic Testing, Others Test Type |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 18.1% of the global high-throughput genomic screening for preventive healthcare market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 412.2 million by 2033.
No credit card required*
Publish Date: Apr 14, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
High-Throughput Genomic Screening For Preventive Healthcare Market Scope
High-Throughput Genomic Screening for Preventive Healthcare Market segmentation & scope
High-Throughput Genomic Screening For Preventive Healthcare Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Illumina Inc | View profile | 9,300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | www.illumina.com |
| Myriad Genetics Inc | View profile | 2,700 | 320 Wakara Way, Salt Lake City, UT, United States, 84108 | www.myriad.com |
| Exact Sciences Corp | View profile | 6,600 | 5505 Endeavor Lane, Madison, WI, United States, 53719 | www.exactsciences.com |
| Natera Inc | View profile | 3,293 | 13011 McCallen Pass, Building A Suite 100, Austin, TX, United States, 78753 | www.natera.com |
| Fulgent Genetics Inc | View profile | 1,012 | 4399 Santa Anita Avenue, El Monte, CA, United States, 91731 | www.fulgentgenetics.com |
| Pacific Biosciences of California Inc | View profile | 796 | 1305 O’Brien Drive, Menlo Park, CA, United States, 94025 | www.pacb.com |
| 23andMe Holding Co Class A | View profile | 816 | 349 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 | www.23andme.com |
| 10x Genomics Inc Ordinary Shares - Class A | View profile | 1,259 | 6230 Stoneridge Mall Road, Pleasanton, CA, United States, 94588 | www.10xgenomics.com |
| BGI Group | View profile | 5001-10000 | Shenzhen, Guangdong, China, Asia | www.genomics.cn/ |
Asia Pacific High-Throughput Genomic Screening for Preventive Healthcare Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to High-Throughput Genomic Screening for Preventive Healthcare Market Outlook will help companies and investors design strategic landscapes.
Non-Invasive Prenatal Testing (Nipt) was the largest segment with a revenue share of 34.07% in 2025.
Horizon Databook has segmented the Asia Pacific high-throughput genomic screening for preventive healthcare market based on carrier screening, predictive / presymptomatic testing, non-invasive prenatal testing (nipt), preimplantation genetic testing (pgt), newborn screening, pharmacogenomic testing, others test type covering the revenue growth of each sub-segment from 2021 to 2033.
- Asia Pacific High-Throughput Genomic Screening For Preventive Healthcare Market Test Type Outlook (Revenue, USD Million , 2021-2033)
- Carrier Screening
- Predictive / Presymptomatic Testing
- Non-Invasive Prenatal Testing (NIPT)
- Preimplantation Genetic Testing (PGT)
- Newborn Screening
- Pharmacogenomic Testing
- Others Test Type
- Asia Pacific High-Throughput Genomic Screening For Preventive Healthcare Market Technology Outlook (Revenue, USD Million , 2021-2033)
- Next-Generation Sequencing (NGS)
- Microarray-based analysis
- PCR (Polymerase Chain Reaction)
- FISH (Fluorescence in situ hybridization)
- CRISPR-based screening platforms
- Others Technology
- Asia Pacific High-Throughput Genomic Screening For Preventive Healthcare Market Application Outlook (Revenue, USD Million , 2021-2033)
- Oncology
- Cardiovascular diseases
- Reproductive health & fertility
- Neurodegenerative disorders
- Rare genetic diseases
- Metabolic & chronic disease risk profiling
- Others Application
- Asia Pacific High-Throughput Genomic Screening For Preventive Healthcare Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Hospitals & Diagnostic Laboratories
- Specialized Genomic Labs
- Direct-to-Consumer (DTC) Companies
- Research Institutes & Biopharma Companies
- Genetic Counseling Centers
Reasons to subscribe to High-Throughput Genomic Screening for Preventive Healthcare Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of High-Throughput Genomic Screening for Preventive Healthcare Market Outlook databook
- Our clientele includes a mix of High-Throughput Genomic Screening for Preventive Healthcare Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific High-Throughput Genomic Screening for Preventive Healthcare Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific High-Throughput Genomic Screening for Preventive Healthcare Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Asia Pacific High-Throughput Genomic Screening For Preventive Healthcare Market, 2021-2033 (US$M)
Asia Pacific Test Type - High-throughput Genomic Screening For Preventive Healthcare Market Statistics, 2025 - 2033 (US$M)
